Structure |
Chemical Name |
CAS |
MF |
|
AMinotriclabendazole hydrochloride |
1448346-37-9 |
C13H9Cl4N3O |
|
Oxfendazole-D3(Fenbendazole sulfoxide-D3) |
1228182-54-4 |
C15H13N3O3S |
|
Oxolinic acid-D5 |
1189890-98-9 |
C13H11NO5 |
|
Sulfapyrazole-13C6 |
1420043-51-1 |
|
|
4'-CHLORODIAZEPAM, DESMETHYL- |
|
C15H10Cl2N2O |
|
Cyclopentylalbendazole sulfone |
1448346-31-3 |
C14H17N3O4S |
|
Zilpaterol-13C3 hydrochloride |
1613439-55-6 |
|
|
102767-28-2 |
102767-28-2 |
|
|
IOFETAMINE HCL |
95896-48-3 |
C12H18IN.ClH |
|
(-)-N-METHYLPHYSOSTIGMINE |
103877-07-2 |
C16H23N3O2 |
|
Xylazine-D6 |
1228182-53-3 |
C12H16N2S |
|
Luxabendazole-D3 |
1448346-27-7 |
C15H12FN3O5S |
|
(±)-Nicotine-d3 |
1173021-00-5 |
C17H17D3N2O3 |
|
Ciprofloxacin-D8 hydrochloride hydrate (see Data Sheet) |
1216659-54-9 |
C17H11ClD8FN3O3 |
|
KetaMine-D3 hydrochloride |
1073254-49-5 |
C13H17Cl2NO |
|
Sulfaphenazole-13C6 |
1420043-53-3 |
|
|
Benzoylecgonine tetrahydrate
|
5928-96-1 |
C16H21NO5 |
|
Tamoxifen-13C2,15N solution
|
|
C26H29NO |
|
S(-)-SCH-23388 NOR METHYL- HCL |
107128-79-0 |
C16H16ClNO |
|
TrifluproMazine Hydrochloride-d6 |
1416711-36-8 |
C18H20ClF3N2S |
|
Butyl Paraben-13C6 |
1416711-53-9 |
C11H14O3 |
|
Pirbuterol-D9 acetate |
1431291-46-1 |
C14H24N2O5 |
|
(±)-N-ethyl-alpha-methylphenethylamine hydrochloride |
16105-78-5 |
C11H17N.ClH |
|
cis-Tamoxifen-13C2,15N solution
|
|
C26H29NO |
|
(+/-)-N-HYDROXY-3 4-METHYLENEDIOXYAMPHE& |
114562-59-3 |
C10H13NO3 |
|
5-ALLYL-5-ISOBUTYLBARBITURIC ACID-RING-13C4 |
|
C11H16N2O3 |
|
Nitrofurantoin-13C3 |
1217226-46-4 |
C8H6N4O5 |
|
Cyclopentylalbendazole |
77723-30-9 |
C14H17N3O2S |
|
HydroxyMethylclenbuterol hydrochloride |
37162-89-3 |
C12H19Cl3N2O2 |
|
Difloxacin-D3 hydrochloride hydrate(see Data Sheet) |
1173021-89-0 |
C21H20ClF2N3O3 |
|
Phenylbutazone-13C12 |
1325559-13-4 |
|
|
()-Eseroline fumarate salt
|
70310-73-5 |
C17H22N2O5 |
|
N-ALLYLNORMETAZOCINE |
14198-28-8 |
C17H23NO |
|
hydroxocobalamin monohydrochloride |
59461-30-2 |
C62H89ClCoN13O15P |